Vaccination

Moderna to build UK centre for mRNA vaccines

Moderna and the UK government on Wednesday announced a deal for the US biotech firm to build a cutting-edge centre to develop and produce mRNA vaccines for respiratory diseases, including COVID.

Medications

AstraZeneca in Algeria $125 mn pharmaceuticals deal

British pharmaceuticals giant AstraZeneca plc signed Tuesday a deal with private Algerian firms Salhi and Hasnaoui to build a $125 million (112 million euro) plant in the North African country, the partners announced.

Other

Roche to pay $7.1 bn for Telavant Holdings

Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.

page 2 from 9